LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Restricted Cash
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-02-28
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in restricted cash for fiscal 2016 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in restricted cash for fiscal 2015 was -$1.26M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in restricted cash for fiscal 2014 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in restricted cash for fiscal 2013 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 |
| 2015-12-31 | -$1.26M 10-K · filed 2017-02-28 |
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
| 2013-12-31 | $0.00 10-K · filed 2016-11-14 |